Q4 2020 13F Holders as of 31 Dec 2020
-
Type / Class
-
Equity / COM
-
Number of holders
-
140
-
Total 13F shares, excl. options
-
56,362,930
-
Shares change
-
-4,562,638
-
Total reported value, excl. options
-
$323,576,998
-
Value change
-
-$33,068,798
-
Put/Call ratio
-
224%
-
Number of buys
-
78
-
Number of sells
-
-51
-
Price
-
$5.74
Significant Holders of CYMABAY THERAPEUTICS INC - COM (CBAY) as of Q4 2020
165 filings reported holding CBAY - CYMABAY THERAPEUTICS INC - COM as of Q4 2020.
CYMABAY THERAPEUTICS INC - COM (CBAY) has 140 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 56,362,930 shares
.
Largest 10 shareholders include Avoro Capital Advisors LLC (10,300,000 shares), BlackRock Inc. (5,386,244 shares), BOXER CAPITAL, LLC (4,000,000 shares), VANGUARD GROUP INC (3,427,011 shares), BAKER BROS. ADVISORS LP (2,893,276 shares), CITADEL ADVISORS LLC (2,523,425 shares), STATE STREET CORP (1,808,347 shares), Foresite Capital Management IV, LLC (1,787,094 shares), Foresite Capital Management III, LLC (1,641,804 shares), and COMMODORE CAPITAL LP (1,486,107 shares).
This table shows the top 140 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.